Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Romain Deschamps et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Jacqueline Palace, de Sèze et al.|Journal of Neurology|2015Cited by 65